About GLPG3667, the GALARISSO (NCT: 05695950) and GALACELA (NCT: 05856448) studies GLPG3667 is an investigational reversible and selective tyrosine kinase 2 (TYK2) kinase domain inhibitor currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback